Global Autogenous Vaccine for Aquaculture Market By Pathogen (Bacteria, Virus), By End-User (Aquatic Research Institutes, Fish Farming Companies), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Autogenous Vaccine for Aquaculture Market Overview:

The Autogenous Vaccine for Aquaculture Market is projected to reach a valuation of USD 836.10 Mn by 2032 at a CAGR of 8.4%, from USD 344.3 Mn in 2021.

Autogenous vaccines are custom vaccinations made from pathogens (bacteria or viruses) isolated directly from affected farms, and then subsequently deployed under minor use or restricted authorization. Vaccines of this type can help prevent recurring diseases and should be considered as a management option.

Autogenous vaccines that comply with basic quality and safety requirements are a very useful tool for fish health and welfare management. It is considered necessary to take into account the specificities of aquaculture when regulating autogenous vaccines.

Detailed Segmentation:

The global autogenous vaccine for the aquaculture market is segmented on the basis of – Pathogen Type, End-User, and Region.

Based on Pathogen Type

• Bacteria
• Virus

Based on End-User

• Aquatic Research Institutes
• Fish Farming Companies

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics

Disease outbreaks on fish farms are becoming more common, and the increase in fish production across the world are major factor boosting the need for autogenous vaccines to prevent disease. Furthermore, to meet the demand from fish farming enterprises, various autogenous vaccine manufacturers are working on expanding their manufacturing capacities.

The expansion of production capacities by opening new plants for the production of autogenous vaccines by key manufacturers is expected to propel market growth over the forecast period.

However, autogenous vaccine production restrictions differ from country to country. For the manufacture of vaccinations, each country has its own set of legislation and licensing requirements. Some nations have standardized regulations to use fish autogenous vaccines, whereas others have none at all.

Furthermore, autogenous vaccine imports and exports require permission from both nations concerned. As a result, strict regulations and lengthy license procedures are expected to restrain the development of autogenous vaccines for the aquaculture industry.

Key Players:

• IDT Biologika GmbH
• MARINNOVAC Limited
• Ceva Biovac
• Zoetis Inc.
• vaxxinova GmbH
• Barramundi Group
• HIPRA
• AniCon Labor GmbH
• sanphar
• Kennebec River Biosciences
• Other Key Players

Key Developments

• Pharma announced that they are going to produce fish faction in a Chinese development center in Suzhou.
• IDT Biologika GmbH collaborated with Gallant Custom Laboratories and launched a new firm in Canada to enhance their production quantitatively.

For the Autogenous Vaccine for Aquaculture Market research study, the following years have been considered to estimate the market size: